Abstract:The varied ways in which mutations in presenilins (PSEN1 and PSEN2) affect amyloid β precursor protein (APP) processing in causing early–onset familial Alzheimer disease (FAD) are complex and not properly understood. Many recent lines of evidence also suggest that clinical PSEN mutations, in addition to increasing Aβ42 can also cause PSEN loss of function. (1) To develop a highly reproducible in vitro assay for not only comparing Aβ42/Aβ40 ratio between different PSEN mutations, but also evaluating individual contributions of Aβ42 and Aβ40 to this ratio. (2) To test whether PSEN mutations cause a clinically relevant increase in Aβ42 or a decrease in Aβ40, and whether these changes corroborate with brain depositions. Aβ and APP processing were studied for a well–represented set of nine clinical PSEN mutations (PSEN1– A79V, I143T, A231V, L262F, C263F, L282V, G384A, Δ9 and PSEN2– N141I) on a novel, ELISA–based in vitro assay. The assay was well–normalized for PSEN and APP/Sw transfection and also for cellular viability. Correlations were made with mean age–of–onset. Brain Aβ40 and Aβ42 levels in 6 mutations were also analyzed by image densitometry and mass spectrometry, and were correlated with the in vitro data. All mutations significantly increased Aβ42/Aβ40 in vitro by significantly decreasing Aβ40 with accumulation of APP C–terminal fragments, a sign of decreased PSEN activity. Aβ42 was also significantly elevated for PSEN1– I143T, G384A, Δ9, and PSEN2– N141I. Age–of–onset of PSEN1–linked FAD correlated inversely with Aβ42/Aβ40 (r = – 0.89; P = 0.001) and absolute levels of Aβ42 (r = – 0.83; P = 0.006), but directly with Aβ40 levels (r = 0.69; P = 0.035). These changes also partly correlated with brain Aβ levels. Our data suggest that a decrease of Aβ40 by FAD–linked PSEN mutations is perhaps as important as an increase in Aβ42. The direct correlation of Aβ40 with age–of–onset suggests that Aβ40 might be protective by perhaps sequestering the more toxic Aβ42 and facilitating its clearance. Also, the in vitro method we describe here is a valid tool for assaying the pathogenic potential of clinical PSEN mutations in a molecular diagnostic setting.

Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio in Vitro and in Vivo

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

The E280A Presenilin 1 Alzheimer Mutation Produces Increased Aβ42 Deposition and Severe Cerebellar Pathology

Presenilin 1 Mutations Linked to Familial Alzheimer's Disease Increase the Intracellular Levels of Amyloid Β‐protein 1–42 and Its N‐Terminally Truncated Variant(s) Which Are Generated at Distinct Sites

Effect of Presenilin Mutations on APP Cleavage; Insights into the Pathogenesis of FAD

Familial Alzheimer Disease-linked Presenilin 1 Variants Enhance Production of Both Aβ1–40 and Aβ1–42 Peptides That Are Only Partially Sensitive to a Potent Aspartyl Protease Transition State Inhibitor of “Γ-Secretase”

Random Mutagenesis of Presenilin-1 Identifies Novel Mutants Exclusively Generating Long Amyloid β-Peptides

The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Aβ43 and atypical clinical manifestations

Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo.

S4-03-01: Evidence That Aberrant Post-Tgn Trafficking of Alzheimer’s APP is Sufficient to Elevate Brain A-beta 42 and May Underlie Mutant Presenilin Action

A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Aβ42/Aβ40 Ratio.

A Novel Presenilin 1 Mutation (F388L) Identified in a Chinese Family with Early-Onset Alzheimer's Disease.

FAD-linked Mutations in Presenilin 1 Alter the Length of Abeta Peptides Derived from Betaapp Transmembrane Domain Mutants.

Mean Age-Of-Onset of Familial Alzheimer Disease Caused by Presenilin Mutations Correlates with Both Increased A Beta 42 and Decreased A Beta 40

P3-395: Mean Age-of-onset of Familial Alzheimer Disease Caused by Presenilin Mutations Correlates with Both Increased Aβ42 and Decreased Aβ40

Mutation Analysis of Presenilin-1 Gene in Alzheimer' S Disease Patients and the Effects of Its Mutation on Expression of Presenilin-1 and Amyloid Precursor Protein

Cholinergic-like neurons and cerebral spheroids bearing the PSEN1 p.Ile416Thr variant mirror Alzheimer's disease neuropathology

Aβ42/Aβ40 Ratios of Presenilin 1 Mutations Correlate with Clinical Onset of Alzheimer’s Disease

PS1 Affects the Pathology of Alzheimer’s Disease by Regulating BACE1 Distribution in the ER and BACE1 Maturation in the Golgi Apparatus

A Presenilin-1 Mutation Identified in Familial Alzheimer Disease with Cotton Wool Plaques Causes a Nearly Complete Loss of Γ-Secretase Activity

Impairments in Fast Axonal Transport and Motor Neuron Deficits in Transgenic Mice Expressing Familial Alzheimer's Disease-Linked Mutant Presenilin 1